← Research libraryCT / 06

Growth-hormone secretagogue

Ipamorelin

Ipamorelin acetate

Not FDA-approved

A synthetic pentapeptide studied as a selective ghrelin-receptor agonist and growth-hormone secretagogue.

FULL RESEARCH GRAPHIC

Ipamorelin research overview

A dedicated overview of ghrelin-receptor signaling, growth-hormone release research, and the 10 mg vial.

Tap the graphic to open the full-resolution version.

CYBERTIDE // VISUAL PROFILEIpamorelin

PROFILE06

IDENTITYIpamorelin acetateGrowth-hormone secretagogue

RESEARCH SIGNAL MAP

04 ACTIVE FIELDS

NODE 01Ghrelin receptor

NODE 02Growth-hormone signaling

NODE 03Gastrointestinal motility

NODE 04Endocrine response

EVIDENCE READOUT

Not FDA-approved

Research on receptor activity does not establish a safe or effective wellness protocol. Evidence varies substantially by route and population.

BOUNDARY CHECK

CONTEXT REQUIRED

FDA identifies immunogenicity, aggregation, impurity, and route-specific safety concerns for compounded ipamorelin acetate.

SUBMITTED LAB DOCUMENTS

Test results

Reports may describe other strengths or blends. Match the labeled amount, composition, and exact lot to your vial. A report for another strength does not verify your vial. Each record identifies whether an exact lot was supplied.

VIAL REFERENCE

3 mL mixing math & dosing context

Every number is labeled by evidence level. The 3 mL reference calculates concentration and U-100 volume; it does not prove solvent compatibility, sterility, stability, or suitability for injection.

VIAL STRENGTH

10 mg vial

AFTER 3.0 mL3.33 mg/mL0.03 mg per U-100 unit

AMOUNTVOLUMEU-100

100 mcg0.03 mL3 units

200 mcg0.06 mL6 units

300 mcg0.09 mL9 units

LIVE CALCULATOR

Change the liquid. See the amount.

U-100

WATER ADDED

Enter the total liquid added to the vial.SYRINGE DRAW

units

10 U-100 units always equals 0.1 mL.

CONCENTRATION3.333 mg/mL

DRAW VOLUME0.1 mL

AMOUNT IN THAT DRAW0.333 mg333.3 mcg

Calculation only: vial amount ÷ liquid volume × draw volume. It does not determine what dose to use or confirm product compatibility.

01 / MIXING REFERENCE

3.0 mL BAC-water workflow

First confirm that bacteriostatic water and a 3.0 mL final volume are compatible with the exact product and vial capacity.
Clean both vial stoppers with alcohol and allow them to dry.
Add the 3.0 mL slowly down the inside wall instead of directing pressure onto the powder.
Gently roll or swirl until dissolved; do not shake.
Use product-specific refrigeration and discard guidance. If none exists, do not invent a beyond-use date.

HUMAN-STUDY CONTEXT

Human PK study used controlled IV dose escalation

A small healthy-volunteer study evaluated 15-minute intravenous infusions across five weight-based dose levels. It did not establish the common fixed-dose subcutaneous protocols circulated online.

Primary study — ipamorelin PK/PD ↗

U-100 means 100 units = 1.0 mL. Any table result above 100 units exceeds one standard 1 mL U-100 syringe.

PRIMARY CONTEXTFDA — compounding safety risks

Open source ↗

NEXT INFOGRAPHICWolverine Blend →